Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs Yarrow Bioscience, Inc (YARW)

Cue Biopharma, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Cue Biopharma, Inc. and Yarrow Bioscience, Inc are of similar size ($147.2M and $136.1M). Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against 1.26%. Cue Biopharma, Inc. has the higher net margin (−435.8% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Cue Biopharma, Inc. leads on 9 and Yarrow Bioscience, Inc on 6.

Valuation

Metric CUE YARW Biotechnology median
P/E n/m n/m 10.60
P/S 3.15 27.77 9.40
P/B 51.41 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.74 118.48 9.02
Earnings yield (143.53%) (138.76%) (32.88%)
Free cash flow yield (42.21%) (127.91%) (23.13%)

Profitability

Metric CUE YARW Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (262.03%) (4,134.44%) 0.00%
Net margin (435.83%) (3,881.54%) 0.00%
Free cash flow margin (133.13%) (3,513.07%) 0.00%
Return on equity (1,603.48%) (61.40%) (51.96%)
Return on assets (459.60%) (54.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUE YARW Biotechnology median
Revenue growth (TTM) 354.37% 1.26% 6.76%
EPS growth (last fiscal year) 61.11% 32.26% 29.88%
Revenue growth, 5-year CAGR 54.16% (51.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 15.26 4.97
Net debt to EBITDA 1.10 0.95 1.01

Dividend

Metric CUE YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric CUE YARW Biotechnology median
Market cap 136.06m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack